Clinical trial
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
NCT00165152 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00165152 |
|---|---|
| Title | Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing |
| Official title | A Randomized Study of Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Massachusetts General Hospital Beth Israel Deaconess Medical Center Medical University of South Carolina National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Breast Cancer, Ovarian Cancer |
| Intervention type | Procedure |
| Interventions | Genetic Counseling, Informed Consent Counseling |
| Enrollment | 150 |
| Start date | Jul 1, 1998 |
| Primary completion | Sep 1, 2001 |
| Completion | Jun 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | Aug 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: